- Home
- ALTI vs MNPR Comparison
ALTI vs MNPR Comparison
Compare ALTI & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTI
- MNPR
- Stock Information
- Founded
- ALTI 2020
- MNPR 2014
- Country
- ALTI United States
- MNPR United States
- Employees
- ALTI N/A
- MNPR N/A
- Industry
- ALTI Investment Managers
- MNPR Biotechnology: Pharmaceutical Preparations
- Sector
- ALTI Finance
- MNPR Health Care
- Exchange
- ALTI Nasdaq
- MNPR Nasdaq
- Market Cap
- ALTI 302.7M
- MNPR 244.1M
- IPO Year
- ALTI N/A
- MNPR 2019
- Fundamental
- Price
- ALTI $3.26
- MNPR $39.59
- Analyst Decision
- ALTI
- MNPR Strong Buy
- Analyst Count
- ALTI 0
- MNPR 5
- Target Price
- ALTI N/A
- MNPR $59.50
- AVG Volume (30 Days)
- ALTI 128.4K
- MNPR 27.1K
- Earning Date
- ALTI 05-09-2025
- MNPR 05-08-2025
- Dividend Yield
- ALTI N/A
- MNPR N/A
- EPS Growth
- ALTI N/A
- MNPR N/A
- EPS
- ALTI N/A
- MNPR N/A
- Revenue
- ALTI $206,935,000.00
- MNPR N/A
- Revenue This Year
- ALTI $25.79
- MNPR N/A
- Revenue Next Year
- ALTI $9.88
- MNPR N/A
- P/E Ratio
- ALTI N/A
- MNPR N/A
- Revenue Growth
- ALTI N/A
- MNPR N/A
- 52 Week Low
- ALTI $2.33
- MNPR $1.72
- 52 Week High
- ALTI $5.45
- MNPR $54.30
- Technical
- Relative Strength Index (RSI)
- ALTI 55.89
- MNPR 57.10
- Support Level
- ALTI $2.75
- MNPR $26.06
- Resistance Level
- ALTI $3.40
- MNPR $40.90
- Average True Range (ATR)
- ALTI 0.28
- MNPR 4.78
- MACD
- ALTI 0.06
- MNPR 0.64
- Stochastic Oscillator
- ALTI 82.05
- MNPR 84.89
About ALTI AlTi Global Inc.
AlTi Global Inc is an independent wealth and asset manager providing entrepreneurs, multi-generational families, institutions, and emerging next-generation leaders with fiduciary capabilities as well as alternative investment strategies and advisory services. The firm has business which is organized into two business segments namely: Wealth & Capital Solutions and International Real Estate segment includes providing holistic solutions for wealth management clients through comprehensive range of wealth management services, including investment management and advisory services. International Real Estate segment includes assist investors with real estate co-investments, structuring and selecting partners with a proven track record with risk adjusted return characteristics.
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.